Form 8-A12B - Registration of securities [Section 12(b)]

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

OS THERAPIES INCORPORATED

(Exact name of registrant as specified in its charter)

 

Delaware		82-5118368
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
15825 Shady Grove Road, Suite 135 Rockville, Maryland		20850
(Address of principal executive offices)		(Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be so registered		Name of each exchange on which each class is to be registered
Common Stock, par value $0.001 per share		NYSE American LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-279839

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

 

 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

 

The description of the common stock, par value $0.001 per share (the “Common Stock”), of OS Therapies Incorporated, a Delaware corporation (the “Registrant”), to be registered hereunder is set forth in the section entitled “Description of Capital Stock” contained in the prospectus that forms a part of the Registrant’s Registration Statement on Form S-1 (File No. 333-279839) initially filed with the Securities and Exchange Commission (the “Commission”) on May 30, 2024, as amended from time to time (the “Registration Statement”), and is hereby incorporated by reference. In addition, the description of the Common Stock included in any prospectus relating to the Registration Statement subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits.

 

In accordance with the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on the NYSE American LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Exchange Act, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date: July 30, 2024

 

	OS THERAPIES INCORPORATED
	By:	/s/ Paul A. Romness
	Name:	Paul A. Romness
	Title:	President and Chief Executive Officer

 

 

2

 

---